Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Winter Respiratory Infections Linked to Vitamin D Levels

By BiotechDaily International staff writers
Posted on 30 Jun 2010
The increased incidence of influenza and other viral respiratory tract infections during the winter months may be linked to decreased levels of vitamin D.

Investigators at the Yale University School of Medicine (New Haven, CT, USA) determined serial monthly concentrations of 25-hydroxyvitamin D during the fall and winter 2009–2010 in 198 healthy adults, who did not know which serum components were being measured. The participants were evaluated for the development of any acute respiratory tract infections by investigators who did not know the patients' 25-hydroxyvitamin D concentrations.

Results published in the June 14, 2010, online edition of the journal PloS ONE revealed that 18 participants maintained vitamin D levels of 38 ng/mL or higher during the study period. Of this group only three (16.6 %) developed viral infections. Of the 180 other participants, 81 (45 %) developed viral infections. Those with the higher vitamin D levels also experienced a marked reduction in the number of days required to recover from their respiratory infections.

The investigators concluded that, "Maintenance of a 25-hydroxyvitamin D serum concentration of 38 ng/mL or higher should significantly reduce the incidence of acute viral respiratory tract infections and the burden of illness caused thereby, at least during the fall and winter in temperate zones. The findings of the present study provide direction for and call for future interventional studies examining the efficacy of vitamin D supplementation in reducing the incidence and severity of specific viral infections, including influenza.”

Related Links:

Yale University School of Medicine




comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.